Bicara Therapeutics Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Submission of Matters to a Vote of Security Holders

Other Events

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Other Events

Other Events

Regulation FD Disclosure

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Results of Operations and Financial Condition

7.01,9.01

2.02,7.01,9.01

5.03,9.01

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Free Writing Prospectus

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

No description available

Notice of Effectiveness

Certification of approval for listing and registration on a national securities exchange

Amended Initial Registration Statement

Registration of Securities on Exchange

Amended Initial Registration Statement

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Cohlhepp Ryan

Cohlhepp Ryan

Hyep Ivan

Larson Jennifer

Larson Jennifer

Janus Henderson Group Ltd.

Cohlhepp Ryan

Hyep Ivan

Mazumdar Claire

Cohlhepp Ryan

Hyep Ivan

Mazumdar Claire

Bender Jeremy

Oliger Christy J.

Bender Jeremy

Oliger Christy J.

BlackRock, Inc.

Mazumdar Claire

Mazumdar Claire

Hyep Ivan

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission)